Clinical trial Recruiting at 1 site Observational Ages 2 to 5

Mucosal and Systemic Immunity and Protection Against Flu in 2- to 5-Year-Olds

Official title: Mucosal and Systemic Immunity Correlates of Protection Against Influenza in Young Children (MUSIC-Flu)

Run by National Institute for Communicable Diseases, South Africa · NCT07861854 · Data updated 2026-11-12

This observational study will see if blood and nasal immune responses in children aged 2–5 years can predict who gets influenza during the season.

More Influenza-like Illness trials

Quick facts

Study typeObservational
Ages2 Years to 5 Years
SexAll
Enrollment150 (estimated)
SponsorNational Institute for Communicable Diseases, South Africa
Academic / other
Locations1 site (Jouberton, North West)
StatusRecruiting
StartedMarch 12, 2026
Main results expectedOctober 31, 2026
Study endsOctober 31, 2026
Registry record updatedOctober 6, 2026
Trial IDNCT07861854 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy children aged 2–5 years residing in the selected South African community with consent from a parent or guardian.

Probably not a fit

Children who do not participate or who do not develop influenza during the season may still contribute data but may not receive a direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers in South Africa will follow healthy children 2–5 years old through the influenza season, collecting nasal swabs three times per week and weekly symptom data, with blood samples taken before, during, and after the season to study immune markers in blood and mucosal tissues. They will compare immune responses between children who become infected with influenza or other respiratory viruses and those who remain uninfected. The study aims to identify correlates of protection that may help explain indirect vaccine effects and guide future vaccine strategies. This is an observational effort to understand natural immune responses rather than test a vaccine or a treatment. Results could inform how immune markers relate to protection and transmission in young children."

Why it matters

Potential benefit: If successful, the study could help identify immune markers that predict protection against influenza, guiding vaccine design and public health strategies for children.

How similar studies have gone: Previous work has explored correlates of protection for influenza, but pediatric mucosal and systemic correlates in this age group remain less well defined and this approach is comparatively exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 2-5 years of age (i.e. from the second birthday until 5 years and 11 months of age) at the time of enrolment.

  * Healthy children as established by medical history and clinical examination before entering the study.
  * Parent availability and willingness to provide written informed consent to all study procedures
  * Child planning to reside in the selected community for the duration of the study.

Exclusion Criteria:

* Presence of malnutrition (defined as z score for age \<-2 based on WHO child grown standard at time of screening for eligibility).

  * Presence of any serious systemic disorder determined by medical history and/or physical examination that would compromise the participant's health or is likely to result in non-conformance to the protocol or a child who is on treatment for any chronic medical condition.
  * Prior history of receiving influenza vaccination.
  * Not providing consent for storage and shipment of samples for immunological testing.
  * Parent of participating child not able, available or willing to accept active weekly follow-up by the study staff, performing a twice-weekly caregiver swab and completing symptom diary on an electronic device or any medical condition in the parents that, in the judgment of the investigator, would interfere with or serves as a contraindication to protocol adherence or a parent's ability to give informed consent. History of chronic administration (defined as more than 14 days) of immunosuppressant medications, including corticosteroids, in the last 6 months (those on inhaled or topical steroids may be permitted to participate in the study.
  * Child is HIV-infected as identified by self-report or if screening of study eligibility identifies that the child is HIV-infected.

Where it's running

  • Peri Natal HIV Research Unit
    Jouberton, North West, South Africa
    Recruiting

Study contacts

  • Principal investigator: Cheryl Cohen — MBBCh, FCPath(SA) Micro, PhD
  • Study coordinator: Cheryl Cohen, MBBCh, FCPath(SA) Micro, PhD
  • Email: cherylc@nicd.ac.za
  • Phone: +27 11 3866593

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.